PIK3CA Mutation-Related Tumors
3 clinical trials · Condition
◉ Watch PIK3CA Mutation-Related Tumors
| Record | Firm | Date |
|---|---|---|
| A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations (NCT06132932) | Shanghai Jiatan Pharmatech Co., Ltd | 2021-06-03 |
Track PIK3CA Mutation-Related Tumors automatically
Every clearance here is in the API, with alerts when new ones post.